Systematic Pharmacology-Based Strategy to Explore the Molecular Network Mechanism of Modified Taohong Siwu Decoction in the Treatment of Premature Ovarian Failure

<div>Expression of Smad2/3 in granulosa cells (immunohistochemistry: 400X). (a) Model group, (b) MTHSWD low-dose group, (c) MTHSWD medium-dose group, (d) MTHSWD high-dose group, (e) positive control group, and (f) blank group.</div>

Evidence-Based Complementary and Alternative Medicine

fig13

Figure 13

Figure 13: Systematic Pharmacology-Based Strategy to Explore the Molecular Network Mechanism of Modified Taohong Siwu Decoction in the Treatment of Premature Ovarian Failure 

Figure 13 | Systematic Pharmacology-Based Strategy to Explore the Molecular Network Mechanism of Modified Taohong Siwu Decoction in the Treatment of Premature Ovarian Failure 